| Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept … C Le Tourneau, JP Delord, A Gonçalves, C Gavoille, C Dubot, N Isambert, ... The lancet oncology 16 (13), 1324-1334, 2015 | 1070 | 2015 |
| Genomic characterization of metastatic breast cancers F Bertucci, CKY Ng, A Patsouris, N Droin, S Piscuoglio, N Carbuccia, ... Nature 569 (7757), 560-564, 2019 | 555 | 2019 |
| Mutational profile of metastatic breast cancers: a retrospective analysis C Lefebvre, T Bachelot, T Filleron, M Pedrero, M Campone, JC Soria, ... PLoS medicine 13 (12), e1002201, 2016 | 371 | 2016 |
| Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, TR Frio, ... Molecular oncology 9 (4), 783-790, 2015 | 284 | 2015 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 234 | 2021 |
| Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function K Baba, A Benleulmi-Chaachoua, AS Journé, M Kamal, JL Guillaume, ... Science signaling 6 (296), ra89-ra89, 2013 | 176 | 2013 |
| Delaying surgery for patients with a previous SARS-CoV-2 infection Journal of British Surgery 107 (12), e601-e602, 2020 | 137 | 2020 |
| Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data V Boeva, T Popova, M Lienard, S Toffoli, M Kamal, C Le Tourneau, ... Bioinformatics 30 (24), 3443-3450, 2014 | 123 | 2014 |
| Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers M Kamal, F Gbahou, JL Guillaume, AM Daulat, A Benleulmi-Chaachoua, ... Journal of Biological Chemistry 290 (18), 11537-11546, 2015 | 117 | 2015 |
| Asymmetry of GPCR oligomers supports their functional relevance P Maurice, M Kamal, R Jockers Trends in pharmacological sciences 32 (9), 514-520, 2011 | 112 | 2011 |
| Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet 397 (10272), 387-397, 2021 | 111 | 2021 |
| Treatment algorithms based on tumor molecular profiling: the essence of precision medicine trials C Le Tourneau, M Kamal, AM Tsimberidou, P Bedard, G Pierron, ... Journal of the National Cancer Institute 108 (4), djv362, 2016 | 101 | 2016 |
| Evaluation of appendicitis risk prediction models in adults with suspected appendicitis Journal of British Surgery 107 (1), 73-86, 2020 | 95 | 2020 |
| Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial N Servant, J Roméjon, P Gestraud, P La Rosa, G Lucotte, S Lair, ... Frontiers in genetics 5, 152, 2014 | 93 | 2014 |
| Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of phase III trials E Pons-Tostivint, A Latouche, P Vaflard, F Ricci, D Loirat, S Hescot, ... JCO Precision Oncology 3, 1-10, 2019 | 92 | 2019 |
| Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis M Wassef, V Rodilla, A Teissandier, B Zeitouni, N Gruel, B Sadacca, ... Genes & development 29 (24), 2547-2562, 2015 | 88 | 2015 |
| Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells G Bkaily, S Sleiman, J Stephan, C Asselin, S Choufani, M Kamal, ... Canadian journal of physiology and pharmacology 81 (3), 274-287, 2003 | 88 | 2003 |
| C-mip impairs podocyte proximal signaling and induces heavy proteinuria SY Zhang, M Kamal, K Dahan, A Pawlak, V Ory, D Desvaux, V Audard, ... Science Signaling 3 (122), ra39-ra39, 2010 | 82 | 2010 |
| GPCR-interacting proteins, major players of GPCR function P Maurice, JL Guillaume, A Benleulmi-Chaachoua, AM Daulat, M Kamal, ... Advances in pharmacology 62, 349-380, 2011 | 81 | 2011 |
| Genomics to select treatment for patients with metastatic breast cancer F Andre, T Filleron, M Kamal, F Mosele, M Arnedos, F Dalenc, MP Sablin, ... Nature 610 (7931), 343-348, 2022 | 80 | 2022 |
